More Company News

Mereo BioPharma

Successful end of Phase 2 meeting with FDA
15 Apr 2019Read More

Mereo BioPharma

Publication of F-4
21 Mar 2019Read More

Mereo BioPharma

Filing of F-4
25 Jan 2019Read More

Mereo BioPharma

BGS-649 Phase IIb data to be presented at ENDO 2019
15 Jan 2019Read More

Mereo BioPharma

Positive results from BGS-649 safety extension study
18 Dec 2018Read More

Mereo BioPharma

Proposed combination of Mereo and OncoMed
05 Dec 2018Read More

Mereo BioPharma

First patient dosed in MPH-966 Phase II study
05 Nov 2018Read More

Mereo BioPharma

Completion of enrollment in BPS-804 Phase IIb study
15 Oct 2018Read More

Mereo BioPharma

H118 results
08 Aug 2018Read More

Return to Mereo BioPharma
© 2019 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).